183 related articles for article (PubMed ID: 26558729)
21. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.
Sandison TG; Homsy J; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Kalamya J; Vora N; Kublin J; Kamya MR; Dorsey G; Tappero JW
BMJ; 2011 Mar; 342():d1617. PubMed ID: 21454456
[TBL] [Abstract][Full Text] [Related]
22. Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
Prendergast A; Walker AS; Mulenga V; Chintu C; Gibb DM
Clin Infect Dis; 2011 Apr; 52(7):953-6. PubMed ID: 21427404
[TBL] [Abstract][Full Text] [Related]
23. TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial.
Laurens MB; Mungwira RG; Nyirenda OM; Divala TH; Kanjala M; Muwalo F; Mkandawire FA; Tsirizani L; Nyangulu W; Mwinjiwa E; Taylor TE; Mallewa J; Blackwelder WC; Plowe CV; Laufer MK; van Oosterhout JJ
Trials; 2016 Jul; 17(1):322. PubMed ID: 27431995
[TBL] [Abstract][Full Text] [Related]
24. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
[TBL] [Abstract][Full Text] [Related]
25. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.
Achan J; Kakuru A; Ikilezi G; Ruel T; Clark TD; Nsanzabana C; Charlebois E; Aweeka F; Dorsey G; Rosenthal PJ; Havlir D; Kamya MR
N Engl J Med; 2012 Nov; 367(22):2110-8. PubMed ID: 23190222
[TBL] [Abstract][Full Text] [Related]
26. Effects of cotrimoxazole prophylaxis on
Jiang J; Qin F; Meng S; Nehl EJ; Huang J; Liu Y; Zou J; Dong W; Huang J; Chen H; Zang N; Liang B; Ning C; Liao Y; Luo C; Liu H; Liu X; Wang J; Zhou O; Le T; Ye L; Wu F; Liang H
Emerg Microbes Infect; 2019; 8(1):367-376. PubMed ID: 31851879
[TBL] [Abstract][Full Text] [Related]
27. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.
Ku SW; Jiamsakul A; Joshi K; Pasayan MKU; Widhani A; Chaiwarith R; Kiertiburanakul S; Avihingsanon A; Ly PS; Kumarasamy N; Do CD; Merati TP; Nguyen KV; Kamarulzaman A; Zhang F; Lee MP; Choi JY; Tanuma J; Khusuwan S; Sim BLH; Ng OT; Ratanasuwan W; Ross J; Wong WW;
J Int AIDS Soc; 2019 Mar; 22(3):e25264. PubMed ID: 30924281
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.
Choi SE; Brandeau ML; Bendavid E
Malar J; 2017 Oct; 16(1):403. PubMed ID: 28985732
[TBL] [Abstract][Full Text] [Related]
29. Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon.
Janssen S; Hermans S; Knap M; Moekotte A; Rossatanga EG; Adegnika AA; Bélard S; Hänscheid T; Grobusch MP
PLoS Negl Trop Dis; 2015 May; 9(5):e0003769. PubMed ID: 25993501
[TBL] [Abstract][Full Text] [Related]
30. Cotrimoxazole versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in HIV-infected pregnant women in Bangui, Central African Republic: A pragmatic randomised controlled trial.
Manirakiza A; Tondeur L; Ketta MYB; Sepou A; Serdouma E; Gondje S; Bata GGB; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Briand V; Lombart JP; Vray M
Trop Med Int Health; 2021 Oct; 26(10):1314-1323. PubMed ID: 34407273
[TBL] [Abstract][Full Text] [Related]
31. The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis.
Juma DW; Muiruri P; Yuhas K; John-Stewart G; Ottichilo R; Waitumbi J; Singa B; Polyak C; Kamau E
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007223. PubMed ID: 30897090
[TBL] [Abstract][Full Text] [Related]
32. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.
González R; Desai M; Macete E; Ouma P; Kakolwa MA; Abdulla S; Aponte JJ; Bulo H; Kabanywanyi AM; Katana A; Maculuve S; Mayor A; Nhacolo A; Otieno K; Pahlavan G; Rupérez M; Sevene E; Slutsker L; Vala A; Williamsom J; Menéndez C
PLoS Med; 2014 Sep; 11(9):e1001735. PubMed ID: 25247995
[TBL] [Abstract][Full Text] [Related]
33. Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis.
Mbeye NM; ter Kuile FO; Davies MA; Phiri KS; Egger M; Wandeler G;
Trop Med Int Health; 2014 Sep; 19(9):1057-67. PubMed ID: 25039469
[TBL] [Abstract][Full Text] [Related]
34. Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes.
Francis F; Gough EK; Edens TJ; Berejena C; Bwakura-Dangarembizi M; Shonhai A; Nathoo KJ; Glass M; Gibb DM; Prendergast AJ; Manges AR
J Acquir Immune Defic Syndr; 2020 Dec; 85(5):601-605. PubMed ID: 32852361
[TBL] [Abstract][Full Text] [Related]
35. Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus-Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy.
Kyosiimire-Lugemwa J; Anywaine Z; Abaasa A; Levin J; Gombe B; Musinguzi K; Kaleebu P; Grosskurth H; Munderi P; Pala P
J Infect Dis; 2020 Jul; 222(3):381-390. PubMed ID: 31714954
[TBL] [Abstract][Full Text] [Related]
36. Frequent malaria illness episodes in two Malawian patients on antiretroviral therapy soon after stopping cotrimoxazole preventive therapy.
Nyangulu WJ; Mwinjiwa E; Divala TH; Mungwira RG; Nyirenda O; Kanjala M; Mbambo G; Mallewa J; Taylor TE; Laurens MB; Laufer MK; van Oosterhout JJ
Malawi Med J; 2017 Mar; 29(1):57-60. PubMed ID: 28567199
[TBL] [Abstract][Full Text] [Related]
37. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women.
Natureeba P; Ades V; Luwedde F; Mwesigwa J; Plenty A; Okong P; Charlebois ED; Clark TD; Nzarubara B; Havlir DV; Achan J; Kamya MR; Cohan D; Dorsey G
J Infect Dis; 2014 Dec; 210(12):1938-45. PubMed ID: 24958908
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.
Kamya MR; Kapisi J; Bigira V; Clark TD; Kinara S; Mwangwa F; Muhindo MK; Kakuru A; Aweeka FT; Huang L; Jagannathan P; Achan J; Havlir DV; Rosenthal PJ; Dorsey G
AIDS; 2014 Nov; 28(18):2701-9. PubMed ID: 25493596
[TBL] [Abstract][Full Text] [Related]
39. Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.
Saadani Hassani A; Marston BJ
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S306-17. PubMed ID: 25768870
[TBL] [Abstract][Full Text] [Related]
40. Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.
Prendergast AJ; Bwakura-Dangarembizi M; Mugyenyi P; Lutaakome J; Kekitiinwa A; Thomason MJ; Gibb DM; Walker AS;
AIDS; 2016 Nov; 30(18):2823-2829. PubMed ID: 27662556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
